W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

X

News

18 May, 2023
Communication on the meeting of the Tariff Council on 20 April 2023
read more
18 May, 2023
Communication on the meeting of the Tariff Council on 11 May 2023
read more
16 May, 2023
The Transparency Council meeting 20/2023 on 22 May 2023
read more
16 May, 2023
Opinion of the Transparency Council – desmopressin
read more
16 May, 2023
Opinion of the Transparency Council – fentanyl
read more
16 May, 2023
Opinion of the Transparency Council – paclitaxel
read more
16 May, 2023
Opinion of the Transparency Council – carboplatin
read more
16 May, 2023
Position of the Transparency Council – Forxiga (dapagliflozin)
read more
16 May, 2023
Position of the Transparency Council – Forxiga (dapagliflozin)
read more
16 May, 2023
Opinion of the Transparency Council – e-stethoscopes
read more
16 May, 2023
Opinion of the Transparency Council – health policy programme of the Municipality of Kamieniec Ząbkowicki
read more
16 May, 2023
Opinion of the Transparency Council – health policy programme of the Municipality of Piaseczno
read more
11 May, 2023
The Transparency Council meeting 19/2023 on 15 May 2023
read more
10 May, 2023
Opinion of the Transparency Council – lisinopril + amlodipine
read more
10 May, 2023
Opinion of the Transparency Council – candesartan + amlodipine
read more
10 May, 2023
Opinion of the Transparency Council – candesartan + hydrochlorothiazide
read more
10 May, 2023
Opinion of the Transparency Council – amlodipine + valsartan+ hydrochlorothiazide
read more
10 May, 2023
Opinion of the Transparency Council – amlodipine + valsartan
read more
10 May, 2023
Opinion of the Transparency Council – telmisartan + hydrochlorothiazide
read more
10 May, 2023
Opinion of the Transparency Council – telmisartan + indapamide
read more
10 May, 2023
Opinion of the Transparency Council – valsartan + hydrochlorothiazide
read more
10 May, 2023
Position of the Transparency Council – Tresiba (insulin degludec)
read more
10 May, 2023
Position of the Transparency Council – Welireg (belzutifan)
read more
22 February, 2023
Opinion of the Transparency Council – program polityki zdrowotnej miasta Pszczyna dotyczący cukrzycy typu 2
read more

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑